secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2025-07-16T23:59:59+00:00
Accession:  0001628280-25-035002
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health shareholders approve director elections, equity plan amendment at annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected; top vote-getter Frank Jaumot with 2,798,958 for, lowest Michael Reed with 2,253,524 for.
- Advisory say-on-pay approved with 2,556,545 votes for and 226,342 against.
- Equity plan amendment to increase shares by 1.1M and add 5% annual evergreen passed (2,075,665 for, 723,697 against).
- Grant Thornton LLP ratified as independent auditor for FY2025 with 3,833,735 votes for.
- Approximately 71% of eligible shares voted (3,916,269 of 5,555,116); 1,116,664 broker non-votes on most items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000162828025035002/0001628280-25-035002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000162828025035002/nutx-20250714.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-035002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer